Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Workers - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
21.2 mg/m³
Most sensitive endpoint:
developmental toxicity / teratogenicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
75
Dose descriptor starting point:
NOAEL
Value:
90
Modified dose descriptor starting point:
NOAEC
Value:
1 587 mg/m³
Explanation for the modification of the dose descriptor starting point:
No inhalative study available, according to Guidance on information requirements and chemical safety assessment Chapter R.8 route-to-route extrapolation is possible
AF for dose response relationship:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for differences in duration of exposure:
6
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for interspecies differences (allometric scaling):
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-4 AF does not apply
AF for other interspecies differences:
2.5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for intraspecies differences:
5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for the quality of the whole database:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for remaining uncertainties:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
acute toxicity
Route of original study:
Oral
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
sensitisation (respiratory tract)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
skin irritation/corrosion
DNEL related information

Workers - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.3 mg/kg bw/day
Most sensitive endpoint:
developmental toxicity / teratogenicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
300
Dose descriptor starting point:
NOAEL
Value:
90 mg/kg bw/day
Modified dose descriptor starting point:
NOAEL
Value:
90 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
No long-term dermal exposure study available, according to Guidance on information requirements and chemical safety assessment Chapter R.8 route-to-route extrapolation is possible. The dermal absorption is not expected to be higher than oral absorption, therefore no AF for route-to-route Extrapolation is needed.
AF for dose response relationship:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for differences in duration of exposure:
6
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for interspecies differences (allometric scaling):
4
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-3
AF for other interspecies differences:
2.5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for intraspecies differences:
5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for the quality of the whole database:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for remaining uncertainties:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
Acute/short term exposure
Hazard assessment conclusion:
no DNEL required: short term exposure controlled by conditions for long-term
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
sensitisation (skin)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
skin irritation/corrosion

Workers - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - workers

General Population - Hazard via inhalation route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
350 µg/m³
Most sensitive endpoint:
developmental toxicity / teratogenicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
750
Dose descriptor starting point:
LOAEL
Value:
30 mg/kg bw/day
Modified dose descriptor starting point:
LOAEC
Value:
260 mg/m³
Explanation for the modification of the dose descriptor starting point:
No inhalative study available, according to Guidance on information requirements and chemical safety assessment Chapter R.8 route-to-route extrapolation is possible
AF for dose response relationship:
5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: section 8.4.3.1.
AF for differences in duration of exposure:
6
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for interspecies differences (allometric scaling):
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-4 no AF applies
AF for other interspecies differences:
2.5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for intraspecies differences:
10
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for the quality of the whole database:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for remaining uncertainties:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
acute toxicity
Route of original study:
By inhalation
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
sensitisation (skin)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
skin irritation/corrosion
DNEL related information

General Population - Hazard via dermal route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.01 mg/kg bw/day
Most sensitive endpoint:
developmental toxicity / teratogenicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
3 000
Dose descriptor starting point:
LOAEL
Value:
30
Modified dose descriptor starting point:
LOAEL
Value:
30 mg/kg bw/day
Explanation for the modification of the dose descriptor starting point:
No long-term dermal exposure study available, according to Guidance on information requirements and chemical safety assessment Chapter R.8 route-to-route extrapolation is possible. The dermal absorption is not expected to be higher than oral absorption, therefore no AF for route-to-route Extrapolation is needed.
AF for dose response relationship:
5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: section 8.4.3.1.
AF for differences in duration of exposure:
6
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for interspecies differences (allometric scaling):
4
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-3
AF for other interspecies differences:
2.5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for intraspecies differences:
10
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for the quality of the whole database:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for remaining uncertainties:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
Acute/short term exposure
Hazard assessment conclusion:
no DNEL required: short term exposure controlled by conditions for long-term
DNEL related information

Local effects

Long term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
sensitisation (skin)
Acute/short term exposure
Hazard assessment conclusion:
no hazard identified
Most sensitive endpoint:
skin irritation/corrosion

General Population - Hazard via oral route

Systemic effects

Long term exposure
Hazard assessment conclusion:
DNEL (Derived No Effect Level)
Value:
0.01 mg/kg bw/day
Most sensitive endpoint:
developmental toxicity / teratogenicity
Route of original study:
Oral
DNEL related information
DNEL derivation method:
ECHA REACH Guidance
Overall assessment factor (AF):
3 000
Modified dose descriptor starting point:
LOAEL
Value:
30 mg/kg bw/day
AF for dose response relationship:
5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: section 8.4.3.1.
AF for differences in duration of exposure:
6
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for interspecies differences (allometric scaling):
4
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-3
AF for other interspecies differences:
2.5
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for intraspecies differences:
10
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for the quality of the whole database:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
AF for remaining uncertainties:
1
Justification:
According to Guidance on information requirements and chemical safety assessment Chapter R.8: Table R.8-6
Acute/short term exposure
Hazard assessment conclusion:
low hazard (no threshold derived)
Most sensitive endpoint:
acute toxicity
Route of original study:
Oral
DNEL related information

General Population - Hazard for the eyes

Local effects

Hazard assessment conclusion:
no hazard identified

Additional information - General Population